Clinical Trials Browser

Has results × sapanisertib × Sarcoma × Clear all

NCT02987959 2022-10-14

Study of TAK-228 (MLN0128) in Soft Tissue Sarcomas

Phase 2 Terminated

6 enrolled 10 charts

Sarcoma

NCT02601209 2022-08-23

Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma

Phase 1/2 Terminated

151 enrolled 22 charts

Leiomyosarcoma, Sarcoma, Synovial, Dermatofibrosarcoma, Neurofibrosarcoma, Histiocytoma, Malignant Fibrous